The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Single-institutional analysis of radiotherapy and orthotopic liver transplant for patients with unresectable cholangiocarcinoma.
 
Meng-Lun Hsieh
No Relationships to Disclose
 
Sumehra Hannan
No Relationships to Disclose
 
Steven I. Hanish
No Relationships to Disclose
 
Parsia A. Vagefi
Leadership - Trans Med
Consulting or Advisory Role - Trans Med
 
Amit G. Singal
Consulting or Advisory Role - AstraZeneca; Bayer; Boston Scientific; Eisai Europe; Exact Sciences; Exelixis; FjuFilm Medical Sciences; Genentech; Glycotest; GRAIL; Histosonics
Research Funding - Glycotest
 
Andrew Zhuang Wang
Leadership - Archimmune Therapeutics; Capio BioSciences; Nanorobotics; Novartis (I)
Stock and Other Ownership Interests - Archimmune Therapeutics; Archimmune Therapeutics; Capio BioSciences
Consulting or Advisory Role - Aptitude Health (I); Aravive (I); AVEO (I); Bayer (I); Capio BioSciences; Dendreon (I); Eisai (I); Gerson Lehrman Group; Janssen (I); Kidney Cancer Association (I); Merck KGaA (I); Mirati Therapeutics (I); MJH Associates (I); Peerview (I); PlatformQ Health (I); QED Therapeutics (I); Regeneron (I); Sanofi/Aventis (I); Seagen (I)
Research Funding - Archimmune Therapeutics; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - Biomatrix patent licensed to PhoenixSongs
Travel, Accommodations, Expenses - Exelixis (I); Genentech (I); Pfizer (I); Sanofi (I)
 
Jigesh A. Shah
No Relationships to Disclose
 
Arjmand R. Mufti
No Relationships to Disclose
 
Nina Niu Sanford
Honoraria - AstraZeneca; Total Health Conferencing
 
Madhukar S. Patel
No Relationships to Disclose
 
Nicole E. Rich
Consulting or Advisory Role - AstraZeneca
 
Todd Anthony Aguilera
Stock and Other Ownership Interests - AKSO Biopharmaceutical; Avelas Biosciences
Research Funding - Apexigen (Inst); Galera Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patent from Stanford with royalties for licensing to Akso Biosciences; Patent from UCSD with royalties for licensing to Avelas Biosciences